Total planned funding: $1,718,788,129
Clear active filters
Not Available
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $342,950,710 |
Uganda | $200,879,655 |
Tanzania | $172,360,089 |
South Africa | $169,767,678 |
Nigeria | $151,415,095 |
Zambia | $131,465,131 |
Mozambique | $89,881,345 |
Ethiopia | $86,782,796 |
Côte d'Ivoire | $66,449,591 |
Zimbabwe | $29,448,254 |
Haiti | $29,202,867 |
Namibia | $22,862,760 |
Lesotho | $22,680,282 |
Central America Region | $18,563,538 |
Eswatini | $18,521,505 |
Cameroon | $18,382,258 |
Ukraine | $17,949,720 |
Democratic Republic of the Congo | $13,317,308 |
Caribbean Region | $12,760,189 |
Burundi | $12,131,842 |
Cambodia | $11,243,049 |
Vietnam | $10,727,486 |
Ghana | $10,455,673 |
Botswana | $10,348,000 |
Indonesia | $7,698,911 |
India | $6,450,000 |
Angola | $6,300,000 |
Dominican Republic | $6,131,500 |
Malawi | $5,601,800 |
South Sudan | $4,319,565 |
Central Asia Region | $3,800,000 |
Rwanda | $2,926,785 |
Russia | $2,500,000 |
Papua New Guinea | $1,204,590 |
China | $1,000,000 |
Asia Regional Program | $308,157 |
Burma | $0 |
Program Areas
Prevention | $509,767,665 |
Care | $450,798,156 |
Treatment | $393,624,446 |
Governance and Systems | $245,609,377 |
Testing | $136,053,940 |
Budget Codes
HTXS: Treatment: Adult Treatment | $326,172,825 |
HKID: Care: Orphans and Vulnerable Children | $263,821,520 |
HVOP: Sexual Prevention: Other Sexual Prevention | $195,663,655 |
HVCT: Testing: HIV Testing and Counseling | $136,053,940 |
HBHC: Care: Adult Care and Support | $116,592,241 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $112,483,380 |
OHSS: Health Systems Strengthening | $106,491,284 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $91,584,508 |
HVSI: Strategic Information | $87,620,430 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $67,592,216 |
HLAB: Laboratory Infrastructure | $51,497,663 |
HVTB: Care: TB/HIV | $47,189,998 |
PDTX: Treatment: Pediatric Treatment | $40,032,312 |
HTXD: Treatment: ARV Drugs | $27,419,309 |
HMBL: Biomedical Prevention: Blood Safety | $23,665,950 |
PDCS: Care: Pediatric Care and Support | $23,194,397 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $10,501,285 |
HMIN: Biomedical Prevention: Injection Safety | $8,276,671 |
Top Partner Programs
Not Available:
$1,718,788,129
View countries